Introduction

Risk management plans for genetically modified (GM) organisms are structured measures designed to identify, assess, prevent, minimise, and monitor potential risks to human health, biodiversity, and the environment. They are particularly important when GM crops, genetically engineered microorganisms, or other modified organisms are developed, tested, released, or commercialised.

A risk management plan generally follows a risk assessment and identifies the possible hazards, the likelihood and seriousness of harm, measures to control exposure, monitoring requirements, emergency responses, and responsibilities of the developer and regulatory authorities. It may also require reporting unexpected effects and revising safeguards when new scientific information becomes available.

In India, the regulation of GM organisms is primarily governed by the Environment (Protection) Act, 1986, and the 1989 Rules on the manufacture, use, import, export, and storage of hazardous microorganisms, genetically engineered organisms, or cells. The legal objective is to ensure that scientific innovation proceeds under effective biosafety oversight and does not create unacceptable risks to public health or the environment.

Regulatory Framework and Risk Management Measures

The 1989 Rules establish six competent authorities: the Recombinant DNA Advisory Committee (RDAC), Institutional Biosafety Committee (IBSC), Review Committee on Genetic Manipulation (RCGM), Genetic Engineering Appraisal Committee (GEAC), State Biotechnology Coordination Committee (SBCC), and District Level Committee (DLC). Their functions include scientific review, approval, inspection, monitoring, and enforcement.

GeAC India+1

A comprehensive GMO risk management plan should address:

Risk identification: Potential effects on human health, non-target organisms, biodiversity, and agricultural ecosystems.

Containment and prevention: Isolation distances, controlled field trials, handling procedures, and prevention of unintended release.

Monitoring: Surveillance for unexpected environmental effects, gene flow, and changes in the organism’s behaviour.

Emergency response: An up-to-date on-site emergency plan, reporting procedures, and measures to contain accidental release.

Post-release review: Continued assessment after approval, with corrective action or suspension where new risks are identified.

The 1989 Rules require an on-site emergency plan and provide for regulatory approval of environmental release and field trials. They also permit authorities to direct measures to prevent the discharge or release of genetically engineered organisms.

IndiaCode+1

Important Case Laws

1. Gene Campaign v. Union of India, 2024 INSC 545

The Supreme Court considered challenges to the conditional environmental approval of genetically modified mustard (DMH-11). The case addressed biosafety assessment, regulatory decision-making, expert participation, and the public interest in protecting the environment.

The Court permitted judicial review of decisions made by GMO regulatory bodies. It directed the Union Government to formulate a national policy on GM crops through consultation with experts, farmers, State Governments, and other stakeholders. It also directed that expert credentials be verified and conflicts of interest disclosed and appropriately managed.

The judges delivered separate opinions and differed on the validity of the particular approval. Therefore, the judgment should not be understood as an unconditional judicial endorsement of GM mustard. It establishes the importance of accountable, transparent, and reviewable risk-management decisions.

Indian Kanoon+2

2. Aruna Rodrigues v. Union of India, (2012) 5 SCC 321

This litigation concerning Bt brinjal and GM crop regulation raised questions about biosafety testing, environmental release, and the adequacy of regulatory safeguards. The Supreme Court’s proceedings included the involvement of a Technical Expert Committee.

The case illustrates that risk management must be based on scientific evaluation and must account for potential environmental and health consequences. It also highlights the importance of independent expertise where uncertainty remains.

3. Vellore Citizens’ Welfare Forum v. Union of India, (1996) 5 SCC 647

The Supreme Court recognised the precautionary principle and the polluter-pays principle in Indian environmental law. Although the case concerned industrial pollution rather than GM organisms, its reasoning is relevant by analogy: lack of complete scientific certainty should not prevent reasonable protective measures where serious environmental harm is plausible.

Conclusion

Risk management plans for GM organisms are essential to responsible biotechnology governance. Indian law requires biosafety assessment, regulatory approval, monitoring, and emergency preparedness under the Environment (Protection) Act, 1986, and the 1989 Rules. The Gene Campaign judgment confirms that regulatory decisions are subject to judicial review and that transparent, accountable, stakeholder-informed policy is important. A sound plan must remain responsive to scientific evidence, provide safeguards against unintended release, and ensure that environmental and public-health protection is not sacrificed for technological advancement.